Companies: 10,795·Total market cap: $144.5T
Viridian Therapeutics, Inc.

Viridian Therapeutics, Inc.

VRDNNASDAQHealthcare● Active
$15.73
$-0.05(-0.32%)
Market Cap$1.4B
P/E Ratio
52W High$34.29
52W Low$13.18
Overview

Viridian Therapeutics, Inc.(VRDN)· 现金流量表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · VRDN · 截至 2026-06-10

财务报表

Operating CF · CapEx · Free Cash Flow
Breakdown2025-122024-122023-122022-122021-12
Operating Activities
Net Income($342.60M)($269.95M)($237.73M)($129.87M)($79.41M)
Depreciation & Amort.($6.76M)$0.54M$0.52M$0.26M$0.12M
Stock-Based Comp.$44.30M$42.15M$67.17M$19.77M$14.46M
Change in Working Capital$23.03M$9.60M($9.43M)$15.96M$1.72M
Net Cash from Operations($276.39M)($232.32M)($184.17M)($93.84M)($54.58M)
Investing Activities
Capital Expenditure($0.49M)($0.51M)($0.90M)($0.80M)($0.34M)
Purchases of Investments($579.28M)($695.07M)($407.88M)($223.26M)($188.43M)
Sales of Investments$542.21M$466.93M$314.53M$108.94M$114.40M
Net Cash from Investing($37.56M)($228.65M)($94.25M)($115.13M)($74.29M)
Financing Activities
Common Stock Repurchased$0.00M$0.00M$0.00M$0.00M$0.00M
Dividends Paid$0.00M$0.00M$0.00M$0.00M$0.00M
Debt Issued / Repaid$28.88M$0.00M$15.00M$5.00M$0.00M
Net Cash from Financing$426.74M$457.74M$225.67M$322.24M$125.28M
Free Cash Flow
Free Cash Flow($276.89M)($232.83M)($185.07M)($94.64M)($54.92M)
FCF Margin %(computed)-390.81%

数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · M

深入了解Viridian Therapeutics, Inc.

关于Viridian Therapeutics, Inc.(VRDN)现金流量表

Viridian Therapeutics, Inc. 2025财年经营活动现金流($0.28B),自由现金流($0.28B)(FCF利润率-390.81%),资本支出($0.00B)。

常见问题

VRDN · 4 问

Viridian Therapeutics, Inc. 2025财年自由现金流($0.28B),同比down18.9%。

VRDN free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10